<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="4705">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01699802</url>
  </required_header>
  <id_info>
    <org_study_id>2012/148</org_study_id>
    <nct_id>NCT01699802</nct_id>
  </id_info>
  <brief_title>Influence of Inhaled Anaesthetics on Rebreathing of Carbon Dioxide When Using an Anaesthesia Gas Reflector (AnaConDa)</brief_title>
  <official_title>Influence of Inhaled Anaesthetics on Rebreathing of Carbon Dioxide When Using an Anaesthesia Gas Reflector (AnaConDa)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Region Skane</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Region Skane</source>
  <oversight_info>
    <authority>Sweden: Medical Products Agency</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose is to investigate how the adsorptive capacity of the active carbon filter to
      carbon dioxide in an anaesthetic gas reflector (AnaConDa) is affected by adding inhaled
      anaesthetic agent.

      The hypothesis is that addition of inhaled anaesthetic agent will affect the amount of
      adsorption of carbon dioxide to the active carbon and thereby affect rebreathing of carbon
      dioxide.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2012</start_date>
  <completion_date type="Anticipated">April 2014</completion_date>
  <primary_completion_date type="Anticipated">March 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science</study_design>
  <primary_outcome>
    <measure>Volume of carbon dioxide rebreathing from an anesthetic gas reflector</measure>
    <time_frame>2 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>Tidal carbon dioxide volume rebreathed from an anesthetic gas reflector correlated to concentration of delivered anesthetic gas.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quantification of ventilatory requirements to maintain isocapnia with the use of an anesthetic gas reflector.</measure>
    <time_frame>2 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>Changes of tidal volume required to maintain constant alveolar ventilation will be assessed by continuous measurement of exhaled tidal carbon dioxide volume, the latter to be maintained at a constant value.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">12</enrollment>
  <condition>Ischemic Heart Disease</condition>
  <arm_group>
    <arm_group_label>Inhaled anaesthetic agent</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The group where the investigators adds inhaled anaesthetic agent when using the anaesthetic gas reflector (AnaConda).</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Inhaled anaesthetic agent</intervention_name>
    <arm_group_label>Inhaled anaesthetic agent</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  elective coronary artery by-pass graft surgery

          -  elective valve replacement surgery

          -  normal left ventricular ejection fraction on preoperative echocardiography

        Exclusion Criteria:

          -  obstructive lung disease

          -  restrictive lung disease
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mikael Bodelsson, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Divison of Surgery, Department of Anaesthesia, Skane University Hospital, Lund, Sweden</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gunnar Malmkvist, M.D.  Ph.D.</last_name>
    <phone>+46 46 171035</phone>
    <email>gunnar.malmkvist@skane.se</email>
  </overall_contact>
  <location>
    <facility>
      <name>Skane University Hospital Lund, Cardiothoracic Intensive Care</name>
      <address>
        <city>Lund</city>
        <zip>SE-221 85</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Louise C Walther Sturesson, M.D.</last_name>
      <phone>+46 46 171953</phone>
      <email>louise.walther_sturesson@med.lu.se</email>
    </contact>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>March 4, 2014</lastchanged_date>
  <firstreceived_date>September 25, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
